Former Creighton professor named chief medical officer at 23andMe

Chutes and Ladders

Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter) or Emily Mullin (email | Twitter) and we will feature it here at the end of each week.

Former Creighton professor named chief medical officer at 23andMe

23andMe has appointed Dr. Jill Hagenkord as chief medical officer. Previously, Hagenkord held positions at InVitae, Complete Genomics and iKaryos Diagnostics. She also served as an associate professor of pathology at Creighton University School of Medicine and director of molecular pathology and clinical genomics at Creighton Medical Laboratories. Release

23andMe
Dr. Jill Hagenkord is the new chief medical officer.


Astellas Pharma
Jeffrey Bloss was promoted to senior vice president for the Americas.


Pharma

Astellas Pharma named Jeffrey Bloss as senior vice president for the Americas. Release

Cynthia Butitta joined Kite Pharma as chief operating officer, and Margo Roberts will be Kite's chief scientific officer. Prentice Curry and Scott Navins will be the company's vice president of quality and operations and vice president of corporate controller, respectively. Release

Biotech

Robert Lindsey joined XBiotech as senior vice president of corporate development and general counsel. Release

AIT Laboratories brought on Dr. Kun Ma as its new vice president of science and technology. Release

Sanovas hired Jeff Heer as its chief operating officer. Release

BioRestorative Therapies appointed Dr. Wayne Olan to its scientific advisory board. Release

Tokai Pharmaceuticals appointed Dr. Karen Ferrante as head of R&D and chief medical officer. Release

Alexza Pharmaceuticals ($ALXA) appointed Winston Brown as vice president of quality. Release

Receptos ($RCPT) appointed Mary Lynne Hedley as a director. Release

Keryx ($KERX) has added Brian Adams as vice president and general counsel, Thomas Edwards as vice president of U.S. sales, and Amy Sullivan as vice president of corporate development and public affairs. Release

CRO

WuXi PharmaTech ($WX) appointed Dr. Steve Yang as executive vice president and chief operating officer. Story